{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:14:00Z","timestamp":1786979640007,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00125-019-4913-2","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T07:03:25Z","timestamp":1559545405000},"page":"1638-1646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6136-1836","authenticated-orcid":false,"given":"Shiu Lun","family":"Au Yeung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Mary","family":"Schooling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"4913_CR1","doi-asserted-by":"publisher","first-page":"k2693","DOI":"10.1136\/bmj.k2693","volume":"362","author":"A Douros","year":"2018","unstructured":"Douros A, Dell\u2019Aniello S, Yu OHY, Filion KB, Azoulay L, Suissa S (2018) Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study. BMJ 362:k2693. \n                    https:\/\/doi.org\/10.1136\/bmj.k2693","journal-title":"BMJ"},{"issue":"9","key":"4913_CR2","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1007\/s00125-017-4337-9","volume":"60","author":"SJ Griffin","year":"2017","unstructured":"Griffin SJ, Leaver JK, Irving GJ (2017) Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes. Diabetologia 60(9):1620\u20131629. \n                    https:\/\/doi.org\/10.1007\/s00125-017-4337-9","journal-title":"Diabetologia"},{"issue":"12","key":"4913_CR3","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.2337\/dc12-0788","volume":"35","author":"S Suissa","year":"2012","unstructured":"Suissa S, Azoulay L (2012) Metformin and the risk of cancer: time-related biases in observational studies. Diabetes Care 35(12):2665\u20132673. \n                    https:\/\/doi.org\/10.2337\/dc12-0788","journal-title":"Diabetes Care"},{"issue":"2","key":"4913_CR4","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2337\/dc16-1682","volume":"40","author":"HC Gerstein","year":"2017","unstructured":"Gerstein HC, Pare G, Hess S et al (2017) Growth differentiation factor 15 as a novel biomarker for metformin. Diabetes Care 40(2):280\u2013283. \n                    https:\/\/doi.org\/10.2337\/dc16-1682","journal-title":"Diabetes Care"},{"issue":"2","key":"4913_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/dom.13519","volume":"21","author":"A Natali","year":"2018","unstructured":"Natali A, Nesti L, Venturi E et al (2018) Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: a nested, case-control study. Diabetes Obes Metab 21(2):412\u2013416. \n                    https:\/\/doi.org\/10.1111\/dom.13519","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"4913_CR6","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/eurheartj\/ehq077","volume":"31","author":"S Taddei","year":"2010","unstructured":"Taddei S, Virdis A (2010) Growth differentiation factor-15 and cardiovascular dysfunction and disease: malefactor or innocent bystander? Eur Heart J 31(10):1168\u20131171. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/ehq077","journal-title":"Eur Heart J"},{"issue":"8","key":"4913_CR7","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/jcmm.12830","volume":"20","author":"C Li","year":"2016","unstructured":"Li C, Wang X, Casal I et al (2016) Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer. J Cell Mol Med 20(8):1420\u20131426. \n                    https:\/\/doi.org\/10.1111\/jcmm.12830","journal-title":"J Cell Mol Med"},{"issue":"10","key":"4913_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrcardio.2017.78","volume":"14","author":"MV Holmes","year":"2017","unstructured":"Holmes MV, Ala-Korpela M, Davey Smith G (2017) Mendelian randomization in cardiometabolic disease: challenges in evaluating causality. Nat Rev Cardiol 14(10):577\u2013590. \n                    https:\/\/doi.org\/10.1038\/nrcardio.2017.78","journal-title":"Nat Rev Cardiol"},{"key":"4913_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ebiom.2019.02.021","volume":"41","author":"CL Cheung","year":"2019","unstructured":"Cheung CL, Tan KCB, Au PCM, Li GHY, Cheung BMY (2019) Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: a Mendelian randomization study. EBioMedicine. 41:85\u201390. \n                    https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.021","journal-title":"EBioMedicine."},{"key":"4913_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fgene.2018.00097","volume":"9","author":"J Jiang","year":"2018","unstructured":"Jiang J, Thalamuthu A, Ho JE et al (2018) A meta-analysis of genome-wide association studies of growth differentiation factor-15 concentration in blood. Front Genet 9:97. \n                    https:\/\/doi.org\/10.3389\/fgene.2018.00097","journal-title":"Front Genet"},{"issue":"11","key":"4913_CR11","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1002\/sim.6835","volume":"35","author":"S Burgess","year":"2016","unstructured":"Burgess S, Dudbridge F, Thompson SG (2016) Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med 35(11):1880\u20131906. \n                    https:\/\/doi.org\/10.1002\/sim.6835","journal-title":"Stat Med"},{"issue":"10","key":"4913_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/ng.3396","volume":"47","author":"M Nikpay","year":"2015","unstructured":"Nikpay M, Goel A, Won HH et al (2015) A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 47(10):1121\u20131130. \n                    https:\/\/doi.org\/10.1038\/ng.3396","journal-title":"Nat Genet"},{"issue":"9","key":"4913_CR13","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/s41588-018-0184-y","volume":"50","author":"W Zhou","year":"2018","unstructured":"Zhou W, Nielsen JB, Fritsche LG et al (2018) Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies. Nat Genet 50(9):1335\u20131341. \n                    https:\/\/doi.org\/10.1038\/s41588-018-0184-y","journal-title":"Nat Genet"},{"issue":"3","key":"4913_CR14","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1001779","journal-title":"PLoS Med"},{"issue":"12","key":"4913_CR15","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/nbt.2749","volume":"31","author":"JC Denny","year":"2013","unstructured":"Denny JC, Bastarache L, Ritchie MD et al (2013) Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol 31(12):1102\u20131110. \n                    https:\/\/doi.org\/10.1038\/nbt.2749","journal-title":"Nat Biotechnol"},{"issue":"11","key":"4913_CR16","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan A, Taliun D, Thurner M et al (2018) Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet 50(11):1505\u20131513. \n                    https:\/\/doi.org\/10.1038\/s41588-018-0241-6","journal-title":"Nat Genet"},{"issue":"9","key":"4913_CR17","doi-asserted-by":"publisher","first-page":"e1002383","DOI":"10.1371\/journal.pmed.1002383","volume":"14","author":"E Wheeler","year":"2017","unstructured":"Wheeler E, Leong A, Liu CT et al (2017) Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis. PLoS Med 14(9):e1002383. \n                    https:\/\/doi.org\/10.1371\/journal.pmed.1002383","journal-title":"PLoS Med"},{"issue":"2","key":"4913_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/ng.520","volume":"42","author":"J Dupuis","year":"2010","unstructured":"Dupuis J, Langenberg C, Prokopenko I et al (2010) New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 42(2):105\u2013116. \n                    https:\/\/doi.org\/10.1038\/ng.520","journal-title":"Nat Genet"},{"issue":"11","key":"4913_CR19","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Global Lipids Genetics Consortium, Willer CJ, Schmidt EM et al (2013) Discovery and refinement of loci associated with lipid levels. Nat Genet 45(11):1274\u20131283. \n                    https:\/\/doi.org\/10.1038\/ng.2797","journal-title":"Nat Genet"},{"issue":"7538","key":"4913_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","volume":"518","author":"AE Locke","year":"2015","unstructured":"Locke AE, Kahali B, Berndt SI et al (2015) Genetic studies of body mass index yield new insights for obesity biology. Nature 518(7538):197\u2013206. \n                    https:\/\/doi.org\/10.1038\/nature14177","journal-title":"Nature"},{"key":"4913_CR21","unstructured":"The Neale Lab UK Biobank GWAS. Available from \n                    http:\/\/www.nealelab.is\/uk-biobank\/\n                    \n                   [Accessed: 22 Oct, 2018]"},{"key":"4913_CR22","volume-title":"Fundamentals of biostatistics","author":"B Rosner","year":"1995","unstructured":"Rosner B (1995) Fundamentals of biostatistics, 4th edn. Duxbury Press, Belmont, CA","edition":"4"},{"issue":"3","key":"4913_CR23","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/ije\/dyq151","volume":"40","author":"BL Pierce","year":"2011","unstructured":"Pierce BL, Ahsan H, Vanderweele TJ (2011) Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol 40(3):740\u2013752. \n                    https:\/\/doi.org\/10.1093\/ije\/dyq151","journal-title":"Int J Epidemiol"},{"key":"4913_CR24","doi-asserted-by":"publisher","unstructured":"Hemani G, Zheng J, Elsworth B, et al. (2018) The MR-Base platform supports systematic causal inference across the human phenome. Elife 7. \n                    https:\/\/doi.org\/10.7554\/eLife.34408","DOI":"10.7554\/eLife.34408"},{"issue":"6","key":"4913_CR25","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska OO, Burgess S (2017) MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol 46(6):1734\u20131739. \n                    https:\/\/doi.org\/10.1093\/ije\/dyx034","journal-title":"Int J Epidemiol"},{"issue":"7678","key":"4913_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature24284","volume":"551","author":"K Michailidou","year":"2017","unstructured":"Michailidou K, Lindstrom S, Dennis J et al (2017) Association analysis identifies 65 new breast cancer risk loci. Nature 551(7678):92\u201394. \n                    https:\/\/doi.org\/10.1038\/nature24284","journal-title":"Nature"},{"issue":"11","key":"4913_CR27","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/sim.7221","volume":"36","author":"J Bowden","year":"2017","unstructured":"Bowden J, Del Greco MF, Minelli C, Davey Smith G, Sheehan N, Thompson J (2017) A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization. Stat Med 36(11):1783\u20131802. \n                    https:\/\/doi.org\/10.1002\/sim.7221","journal-title":"Stat Med"},{"issue":"5","key":"4913_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32(5):377\u2013389. \n                    https:\/\/doi.org\/10.1007\/s10654-017-0255-x","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"4913_CR29","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ije\/dyu005","volume":"43","author":"S Burgess","year":"2014","unstructured":"Burgess S (2014) Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome. Int J Epidemiol 43(3):922\u2013929. \n                    https:\/\/doi.org\/10.1093\/ije\/dyu005","journal-title":"Int J Epidemiol"},{"key":"4913_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2016.02.013","volume":"248","author":"C Andersson","year":"2016","unstructured":"Andersson C, Enserro D, Sullivan L et al (2016) Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study. Atherosclerosis 248:245\u2013251. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.02.013","journal-title":"Atherosclerosis"},{"issue":"21","key":"4913_CR31","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1161\/CIRCULATIONAHA.114.011204","volume":"130","author":"L Wallentin","year":"2014","unstructured":"Wallentin L, Hijazi Z, Andersson U et al (2014) Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation 130(21):1847\u20131858. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.011204","journal-title":"Circulation"},{"issue":"12","key":"4913_CR32","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1373\/clinchem.2016.257212","volume":"62","author":"N Pavo","year":"2016","unstructured":"Pavo N, Wurm R, Neuhold S et al (2016) GDF-15 is associated with cancer incidence in patients with type 2 diabetes. Clin Chem 62(12):1612\u20131620. \n                    https:\/\/doi.org\/10.1373\/clinchem.2016.257212","journal-title":"Clin Chem"},{"issue":"16","key":"4913_CR33","first-page":"5034","volume":"63","author":"T Liu","year":"2003","unstructured":"Liu T, Bauskin AR, Zaunders J et al (2003) Macrophage inhibitory cytokine 1 reduces cell adhesion and induces apoptosis in prostate cancer cells. Cancer Res 63(16):5034\u20135040","journal-title":"Cancer Res"},{"issue":"3","key":"4913_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/01.RES.0000202805.73038.48","volume":"98","author":"T Kempf","year":"2006","unstructured":"Kempf T, Eden M, Strelau J et al (2006) The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia\/reperfusion injury. Circ Res 98(3):351\u2013360. \n                    https:\/\/doi.org\/10.1161\/01.RES.0000202805.73038.48","journal-title":"Circ Res"},{"issue":"19","key":"4913_CR35","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1161\/CIRCULATIONAHA.110.979740","volume":"123","author":"LB Daniels","year":"2011","unstructured":"Daniels LB, Clopton P, Laughlin GA, Maisel AS, Barrett-Connor E (2011) Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study. Circulation 123(19):2101\u20132110. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.979740","journal-title":"Circulation"},{"issue":"3","key":"4913_CR36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/01.RES.0000207919.83894.9d","volume":"98","author":"T Ago","year":"2006","unstructured":"Ago T, Sadoshima J (2006) GDF15, a cardioprotective TGF-beta superfamily protein. Circ Res 98(3):294\u2013297. \n                    https:\/\/doi.org\/10.1161\/01.RES.0000207919.83894.9d","journal-title":"Circ Res"},{"issue":"10","key":"4913_CR37","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm.4392","volume":"23","author":"SE Mullican","year":"2017","unstructured":"Mullican SE, Lin-Schmidt X, Chin CN et al (2017) GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med 23(10):1150\u20131157. \n                    https:\/\/doi.org\/10.1038\/nm.4392","journal-title":"Nat Med"},{"issue":"10","key":"4913_CR38","doi-asserted-by":"publisher","first-page":"4983","DOI":"10.1158\/0008-5472.CAN-05-4067","volume":"66","author":"AR Bauskin","year":"2006","unstructured":"Bauskin AR, Brown DA, Kuffner T et al (2006) Role of macrophage inhibitory cytokine-1 in tumorigenesis and diagnosis of cancer. Cancer Res 66(10):4983\u20134986. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4067","journal-title":"Cancer Res"},{"issue":"1","key":"4913_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00125-018-4751-7","volume":"62","author":"X Bao","year":"2019","unstructured":"Bao X, Borne Y, Muhammad IF et al (2019) Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmo Diet and Cancer-Cardiovascular Cohort. Diabetologia. 62(1):78\u201386. \n                    https:\/\/doi.org\/10.1007\/s00125-018-4751-7","journal-title":"Diabetologia."},{"issue":"2","key":"4913_CR40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.2337\/dc11-1465","volume":"35","author":"JA Hirst","year":"2012","unstructured":"Hirst JA, Farmer AJ, Ali R, Roberts NW, Stevens RJ (2012) Quantifying the effect of metformin treatment and dose on glycemic control. Diabetes Care 35(2):446\u2013454. \n                    https:\/\/doi.org\/10.2337\/dc11-1465","journal-title":"Diabetes Care"},{"issue":"4","key":"4913_CR41","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2337\/diacare.16.4.621","volume":"16","author":"DK Nagi","year":"1993","unstructured":"Nagi DK, Yudkin JS (1993) Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups. Diabetes Care 16(4):621\u2013629. \n                    https:\/\/doi.org\/10.2337\/diacare.16.4.621","journal-title":"Diabetes Care"},{"issue":"6","key":"4913_CR42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.clbc.2013.08.012","volume":"13","author":"C Campagnoli","year":"2013","unstructured":"Campagnoli C, Berrino F, Venturelli E et al (2013) Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer. Clin Breast Cancer 13(6):433\u2013438. \n                    https:\/\/doi.org\/10.1016\/j.clbc.2013.08.012","journal-title":"Clin Breast Cancer"},{"key":"4913_CR43","doi-asserted-by":"publisher","unstructured":"Song C, Burgess S, Eicher JD, O\u2019Donnell CJ, Johnson AD (2017) Causal effect of plasminogen activator inhibitor type 1 on coronary heart disease. J Am Heart Assoc 6(6). \n                    https:\/\/doi.org\/10.1161\/JAHA.116.004918","DOI":"10.1161\/JAHA.116.004918"},{"issue":"1","key":"4913_CR44","doi-asserted-by":"publisher","first-page":"e001956","DOI":"10.1161\/CIRCGEN.117.001956","volume":"11","author":"JV Zhao","year":"2018","unstructured":"Zhao JV, Schooling CM (2018) Coagulation factors and the risk of ischemic heart disease: a Mendelian randomization study. Circ Genom Precis Med 11(1):e001956. \n                    https:\/\/doi.org\/10.1161\/CIRCGEN.117.001956","journal-title":"Circ Genom Precis Med"},{"key":"4913_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijcard.2018.05.051","volume":"267","author":"CM Schooling","year":"2018","unstructured":"Schooling CM, Luo S, Au Yeung SL et al (2018) Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation. Int J Cardiol 267:171\u2013176. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2018.05.051","journal-title":"Int J Cardiol"},{"issue":"24","key":"4913_CR46","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","volume":"289","author":"RT Chlebowski","year":"2003","unstructured":"Chlebowski RT, Hendrix SL, Langer RD et al (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women\u2019s Health Initiative Randomized Trial. JAMA 289(24):3243\u20133253. \n                    https:\/\/doi.org\/10.1001\/jama.289.24.3243","journal-title":"JAMA"},{"issue":"10","key":"4913_CR47","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.jacc.2015.12.060","volume":"67","author":"P Wurtz","year":"2016","unstructured":"Wurtz P, Wang Q, Soininen P et al (2016) Metabolomic profiling of statin use and genetic inhibition of HMG-CoA reductase. J Am Coll Cardiol 67(10):1200\u20131210. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2015.12.060","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"4913_CR48","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/eci.12342","volume":"44","author":"CM Schooling","year":"2014","unstructured":"Schooling CM, Au Yeung SL, Leung GM (2014) Why do statins reduce cardiovascular disease more than other lipid modulating therapies? Eur J Clin Investig 44(11):1135\u20131140. \n                    https:\/\/doi.org\/10.1111\/eci.12342","journal-title":"Eur J Clin Investig"},{"issue":"5","key":"4913_CR49","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.cell.2016.10.042","volume":"167","author":"WJ Astle","year":"2016","unstructured":"Astle WJ, Elding H, Jiang T et al (2016) The allelic landscape of human blood cell trait variation and links to common complex disease. Cell 167(5):1415\u20131429 e1419. \n                    https:\/\/doi.org\/10.1016\/j.cell.2016.10.042","journal-title":"Cell"},{"issue":"3","key":"4913_CR50","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","volume":"122","author":"P van der Harst","year":"2018","unstructured":"van der Harst P, Verweij N (2018) Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res 122(3):433\u2013443. \n                    https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.312086","journal-title":"Circ Res"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4913-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-019-4913-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-019-4913-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T20:04:46Z","timestamp":1591128286000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-019-4913-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["4913"],"URL":"https:\/\/doi.org\/10.1007\/s00125-019-4913-2","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"11 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no duality of interest associated with this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}